Anyone can check whether a person has cancer cells in about half a minute with a new high tech to analyze a drop of blood without medical doctors.
The tech is expected to be commercialized within two years, according to a domestic information and telecommunications research institute.
The state-run Electronics and Telecommunications Research Institute (ETRI) announced Wednesday that it has developed a whole blood processing chip and bio-sensor array chip, which enable anyone check diseases or food toxins at an earlier stage.
The whole blood processing chip enables anyone to easily screen cancers within 30 seconds, as it separates even one drop of blood into blood cells and plasma.
Currently, blood cells are separated from blood plasma by using a centrifugal separator, but it requires complicate procedure over a long time with the participation of medical doctors.
Biosensor array chip is a high technology which adds nano particle to toxic substance, making it electrified and then checking whether toxin exists in food or diseases exist.
If the tech is commercialized, quarantines, restaurants and general homes can easily use the device, an ETRI researcher said.
ETRI plans to transfer this technology to on-site diagnosis device makers and it expects that it will be commercialized within two years.
When the transfer is realized, a Korean firm will be able to jump into medical equipment market which have been dominated by global players such as Roche, Siemens and Abbot.